Abstract

e12529Background: The newest 4.2017 version of the NCCN guidelines incorporates the Oncotype DX (ODX) breast cancer (BC) assay into the algorithm for utilization of systemic adjuvant therapy (tx) f...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call